In the last trading session, 1.1 million shares of the Neuronetics Inc (NASDAQ:STIM) were traded, and its beta was 1.85. Most recently the company’s share price was $4.67, and it changed around -$0.19 or -3.91% from the last close, which brings the market valuation of the company to $187.12M. STIM currently trades at a discount to its 52-week high of $5.92, offering almost -26.77% off that amount. The share price’s 52-week low was $0.52, which indicates that the current value has risen by an impressive 88.87% since then. We note from Neuronetics Inc’s average daily trading volume that its 10-day average is 0.95 million shares, with the 3-month average coming to 1.51 million.
Neuronetics Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.50. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 1 recommended STIM as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Neuronetics Inc is expected to report earnings per share of -0.12 for the current quarter.
Neuronetics Inc (NASDAQ:STIM) trade information
Instantly STIM has showed a red trend with a performance of -3.91% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 5.34 on recent trading dayincreased the stock’s daily price by 12.55%. The company’s shares are currently up 190.06% year-to-date, but still down -7.71% over the last five days. On the other hand, Neuronetics Inc (NASDAQ:STIM) is 13.08% up in the 30-day period. We can see from the shorts that 1.99 million shares have been sold at a short interest cover period of 0.97 day(s).
The consensus price target as assigned by Wall Street analysts is $8, which translates to bulls needing to increase their stock price by 41.62% from its current value. Analyst projections state that STIM is forecast to be at a low of $8 and a high of $8.
Neuronetics Inc (STIM) estimates and forecasts
The year-over-year growth rate is expected to be 99.43%, up from the previous year.
Consensus estimates provided by 4 financial analysts predict the company will bring in an average of 29.07M in revenue for the current quarter. 4 analysts expect Neuronetics Inc to make 36.69M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 17.42M and 16.45M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 66.89%. Forecasts for the next quarter put sales growth at 123.05%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 2.87%. Neuronetics Inc earnings are expected to increase by 77.06% in 2025, but the outlook is positive 61.20% per year for the next five years.
Neuronetics Inc (NASDAQ:STIM)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 9.44% of Neuronetics Inc shares, and 57.90% of them are in the hands of institutional investors. The stock currently has a share float of 63.94%. Neuronetics Inc stock is held by 53.0 institutions, with ARCHON CAPITAL MANAGEMENT LLC being the largest institutional investor. By 2024-06-30, it held 8.23% of the shares, which is about 2.47 million shares worth $4.45 million.
CANNELL CAPITAL LLC, with 7.9239% or 2.38 million shares worth $4.29 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 849.5 shares worth $3.97 million, making up 2.80% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 403.88 shares worth around $1.89 million, which represents about 1.33% of the total shares outstanding.
